Target intelligence / Profile preview

Myoregulatory protein

Molecular classification
Micropeptide, Transmembrane protein, SERCA regulator
01

Overview

Myoregulatory proteins are a family of small, single-pass transmembrane micropeptides that play a critical role in regulating calcium homeostasis within muscle cells (Anderson et al., 2015, Cell). This family includes well-known members such as phospholamban (PLN) and sarcolipin (SLN), as well as more recently identified peptides like myoregulin (MLN), endoregulin (ELN), and dwarf open reading frame (DWORF) (Makarewich, 2020, Trends in Cell Biology). These proteins primarily function by interacting with the sarcoplasmic/endoplasmic reticulum calcium ATPase (SERCA) pump, either inhibiting or activating its ability to transport calcium ions from the cytosol into the sarcoplasmic reticulum (Nelson et al., 2016, Science). By modulating SERCA activity, myoregulatory proteins fine-tune the kinetics of muscle relaxation and contraction. Dysregulation or mutations in these proteins are linked to various pathologies, including heart failure and muscular dystrophies, making them attractive targets for therapeutic intervention (Goonasekera et al., 2021, Frontiers in Physiology). Current drug development strategies focus on small molecules or gene therapies designed to disrupt inhibitory interactions or restore healthy calcium cycling in diseased tissues (Trivieri et al., 2020, JACC: Basic to Translational Science).

Other names
MyoregulinPhospholambanSarcolipinDwarf open reading frameEndoregulinAnother-regulinSERCA-regulatory micropeptideRegulin
02

Mechanism of action

Modulation of the Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA) pump activity to regulate calcium sequestration into the sarcoplasmic reticulum (Makarewich, 2020, Trends in Cell Biology).

03

Biological functions

Calcium signalingMuscle contractionSarcoplasmic reticulum calcium transportCalcium homeostasis
04

Disease associations

Heart failureMuscular dystrophyCardiomyopathyAtrial fibrillation
05

Safety considerations

Potential for cardiac arrhythmiasOff-target effects in non-target muscle tissuesImmunogenicity of viral vectors in gene therapy
06

Interacting drugs

Istaroxime

3 more in the full profile.

07

Biomarkers

Phospholamban phosphorylation statusSERCA2a protein expression levelsCytosolic calcium transient kinetics

Beyond the preview

Go deeper on Myoregulatory protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Myoregulatory protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call